Impacts of nanoparticles on cardiovascular diseases: Modulating metabolism and function of endothelial cells

Current Drug Metabolism

Volumn 13, Issue 8, 2012, Pages 1123-1129

  Meng, Jie ^a   Yang, Xian Da ^a,b   Jia, Lee ^c   Liang, Xing Jie ^a   Wang, Chen ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c FUZHOU UNIVERSITY   (China)

Author keywords

Cardiovascular diseases; Endothelial cells; Nanoparticles

Indexed keywords

ACETYLCHOLINE; ARGININE; CARBON NANOTUBE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIUM DERIVED RELAXING FACTOR; FULLERENE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; IRON OXIDE; METAL OXIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MULTI WALLED NANOTUBE; NANOPARTICLE; PADGEM PROTEIN; POLYSILOXANE; PROTEIN KINASE B; SILICON DIOXIDE; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE;

APOPTOSIS; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD FLOW; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CAVEOLA; CELL ADHESION; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL TYPE; CORONARY ARTERY DISEASE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FIBRINOLYSIS; GENE TARGETING; GENE THERAPY; HUMAN; INFLAMMATION; MOLECULARLY TARGETED THERAPY; NONHUMAN; PARTICLE SIZE; REVIEW; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULITIS;

ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; HUMANS; NANOPARTICLES;

EID: 84868032913     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012802850056     Document Type: Review

References (71)

1. Blann, A.D. Assessment of endothelial dysfunction: focus on atherothrombotic disease. Pathophysiol. Haemost. Thromb., 2004, 33(5-6), 256-261.
2. Boos, C.J.; Lip, G.Y.; Blann, A.D. Circulating endothelial cells in cardiovascular disease. J. Am. Coll. Cardiol., 2006, 48(8), 1538-1547.
3. Kaiser, D.R.; Billups, K.; Mason, C.; Wetterling, R.; Lundberg, J.L.; Bank, A.J. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J. Am. Coll. Cardiol., 2004, 43(2), 179-184.
4. Schwartz, B.G.; Economides, C.; Mayeda, G.S.; Burstein, S.; Kloner, R.A. The endothelial cell in health and disease: its function, dysfunction, measurement and therapy. Int. J. Impot. Res., 2010, 22(2), 77-90.
5. Baldwin, A.L.; Thurston, G. Mechanics of endothelial cell architecture and vascular permeability. Crit. Rev. Biomed. Eng., 2001, 29(2), 247-278.
6. Pearson, J.D. Endothelial cell function and thrombosis. Baillieres Best Pract. Res. Clin. Haematol., 1999, 12(3), 329-341.
7. Cines, D.B.; Pollak, E.S.;, Buck, C.A.; Loscalzo, J.; Zimmerman, G.A.; McEver, R.P.; Pober, J.S.; Wick, T.M.; Konkle, B.A.; Schwartz, B.S.; Barnathan, E.S.; McCrae, K.R.; Hug, B.A.; Schmidt, A.M.; Stern, D.M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 1998, 91(10), 3527-3561.
8. Michiels, C. Endothelial Cell Functions. J. Cell Physiol., 2003, 196(3), 430-443.
9. Mackman, N. Regulation of the tissue factor gene. Thromb. Haemost., 1997, 78(1), 747-754.
10. Chen, J.; Bierhaus, A.; Schiekofer, S.; Andrassy, M.; Chen, B.; Stern, D.M.; Nawroth, P.P. Tissue factor - a receptor involved in the control of cellular properties, including angiogenesis. Thromb. Haemost., 2001, 86(1), 334-345.
11. Jia, L.; Furchgott, R.F. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther., 1993, 267(1), 371-378.
12. Furchgott, R.F. The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. J.A.M.A., 1996, 276 (14), 1186-8.
13. Fleming, I.; Bauersachs, J.; Busse, R. Paracrine functions of the coronary vascular endothelium. Mol. Cell Biochem., 1996, 157(1-2), 137-145.
14. Hirata, Y.; Nagata, D.; Suzuki, E.; Nishimatsu, H.; Suzuki, J.; Nagai, R. Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. Int. Heart J., 2010, 51(1), 1-6.
15. Muller, W.A. Leukocyte-endothelial cell interactions in the inflammatory response. Lab. Invest., 2002, 82(5), 521-533.
16. Krishnaswamy, G.; Kelley, J.; Yerra, L.; Smith, J.K.; Chi, D.S. Human endothelium as a source of multifunctional cytokines: Molecular regulation and possible role in human disease. J. Interferon Cytokine Res., 1999, 19(2), 91-104.
17. Young, J.L.; Libby, P.; Schönbeck, U. Cytokines in the pathogenesis of atherosclerosis. Thromb. Haemost., 2002, 88(4), 554-567.
18. Cybulsky, M.I.; Gimbrone Jr. M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science, 1991, 251(4995), 788-791.
19. Rothlein, R.; Dustin, M.L.; Marlin, S.D.; Springer, T.A. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol., 1986, 137(4), 1270-1274.
20. Yang, L.; Froio, R.M.; Sciuto, T.E.; Dvorak, A.M.; Alon, R.; Luscinskas, F.W. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alphaactivated vascular endothelium under flow. Blood, 2005, 106(2), 584-592.
21. Glass, C.K.; Witztum, J.L. Atherosclerosis. The road ahead. Cell, 2001, 104(4), 503-516.
22. Davignon, J.; Ganz, P. Role of endothelial dysfunction in atherosclerosis. Circulation, 2004, 23 Suppl 1, III27-32.
23. Fichtlscherer, S.; Rosenberger, G.; Walter, D.H.; Breuer, S.; Dimmeler, S.; Zeiher, A.M. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation, 2000, 102(9), 1000-1006.
24. Henderson, A.H. St Cyres lecture. Endothelium in control. Br. Heart J., 1991, 65(5), 116-125.
25. Liang, X.J.; Chen, C.Y.; Zhao, Y.L.; Jia, L.; Wang, P.C. Biopharmaceutics and Therapeutic Potential of Engineered Nanomaterials. Curr. Drug Metab., 2008, 9(8), 697-709.
26. Meng, J.; Wang, D.L.; Wang, P.C.; Jia, L.; Chen, C.; Liang, X.J. Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics. J. Nanosci. Nanotechnol., 2010, 10(12), 8610-8616.
27. Panyam, J.; Labhasetwar, V. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm. Res., 2003, 20(2), 212-220.
28. Blackwell, J.E.; Dagia, N.M.; Dickerson, J.B.; Berg, E.L.; Goetz, D.J. Ligand coated nanosphere adhesion to E- and P-selectin under static and flow conditions. Ann. Biomed. Eng., 2001, 29(6), 523-533.
29. Naota, M.; Shimada, A.; Morita, T.; Inoue, K.; Takano, H. Translocation pathway of the intratracheally instilled C60 fullerene from the lung into the blood circulation in the mouse: possible association of diffusion and caveolae-mediated pinocytosis. Toxicol. Pathol., 2009, 37(4), 456-462.
30. Nishikawa, T.; Iwakiri, N.; Kaneko, Y.; Taguchi, A.; Fukushima, K.; Mori, H.; Morone, N.; Kadokawa, J. Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae. Biomacromolecules, 2009, 10(8), 2074-2085.
31. Fröhlich, E.; Samberger, C.; Kueznik, T.; Absenger, M.; Roblegg, E.; Zimmer, A.; Pieber, T.R. Cytotoxicity of nanoparticles independent from oxidative stress. J. Toxicol. Sci., 2009, 34(4), 363-75.
32. Song, C.; Labhasetwar, V.; Cui, X.; Underwood, T.; Levy, R.J. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model. J. Control. Release, 1998, 54(2), 201-211.
33. Lin, A.; Sabnis, A.; Kona, S.; Nattama, S.; Patel, H.; Dong, J.F.; Nguyen, K.T. Shear-regulated uptake of nanoparticles by endothelial cells and development of endothelial-targeting nanoparticles. J. Biomed. Mater. Res. A, 2010, 93(3), 833-842.
34. Dickerson, J.B.; Blackwell, J.E.; Ou, J.J.; Shinde Patil, V.R.; Goetz, D.J. Limited adhesion of biodegradable microspheres to E- and Pselectin under flow. Biotechnol. Bioeng., 2001, 73(6), 500-509.
35. Eniola, A.O.; Krasik, E.F.; Smith, L.A.; Song, G.; Hammer, D.A. I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow. Biophys. J., 2005, 89(5), 3577-3588.
36. Eniola, A.O.; Hammer, D.A. In vitro characterization of leukocyte mimetic for targeting therapeutics to the endothelium using two receptors. Biomaterials, 2005, 26(34), 7136-7144.
37. Kumar, R.A.; Dong, J.F.; Thaggard, J.A.; Cruz, M.A.; Lopez, J.A.; McIntire, L.V. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: Effect of GPIbalpha mutations on the association and dissociation rates. Biophys. J., 2003, 85(6), 4099-4109.
38. Chen, J.; Lopez, J.A. Interactions of platelets with subendothelium and endothelium. Microcirculation, 2005, 12(3), 235-246.
39. Gojova, A.; Lee, J.T.; Jung, H.S.; Guo, B.; Barakat, A.I.; Kennedy, I.M. Effect of cerium oxide nanoparticles on inflammation in vascular endothelial cells. Inhal. Toxicol, 2009, 21 Suppl 1, 123-130.
40. Gojova, A.; Guo, B.; Kota, R.S.; Rutledge, J.C.; Kennedy, I.M.; Barakat, A.I. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition. Environ. Health Perspect, 2007, 115(3), 403-409.
41. Xia, T.; Kovochich, M.; Liong, M.; Zink, J.I.; Nel, A.E. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. A.C.S. Nano, 2008, 2(1), 85-96.
42. Elgrabli, D.; Floriani, M.; Abella-Gallart, S.; Meunier, L.; Gamez, C.; Delalain, P.; Rogerieux, F.; Boczkowski, J.; Lacroix, G. Biodistribution and clearance of instilled carbon nanotubes in rat lung. Part. Fibre Toxicol, 2008, 5, 20-33.
43. Mercer, R.R.; Hubbs, A.F.; Scabilloni, J.F.; Wang, L.Y.; Battelli, L.A.; Schwegler-Berry, D.; Castranova, V.; Porter, D.W. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part. Fibre Toxicol, 2010, 7, 28-39.
44. Albini, A.; Mussi, V.; Parodi, A.; Ventura, A.; Principi, E.; Tegami, S.; Rocchia, M.; Francheschi, E.; Sogno, I.; Cammarota, R.; Finzi, G.; Sessa, F.; Noonan, D.M.; Valbusa, U. Interactions of single-wall carbon nanotubes with endothelial cells. Nanomedicine, 2010, 6(2), 277-288.
45. Sattar, N. Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease? Clin. Sci. (Lond), 2004, 106(5), 443-445.
46. Niu, J.; Azfer, A.; Rogers, L.M.; Wang, X.; Kolattukudt, P.E. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc. Res., 2007, 73(3), 549-559.
47. Tsou, T.C.; Yeh, S.C.; Tsai, F.Y.; Lin, H.J.; Cheng, T.J.; Chao, H.R.; Tai, L.A. Zinc oxide particles induce inflammatory responses in vascular endothelial cells via NF-KB signaling. J. Hazard. Mater., 2010, 183(1-3), 182-188.
48. Frampton, M.W.; Stewart, J.C.; Oberdoster, G.; Morrow, P.E.; Chalupa, D.; Pietropaoli, A.P.; Frasier, L.M.; Dpeers, D.M.; Huang, L.S.; Utell, M.J. Inhalation of ultrafine particles alters blood leukocytes expression of adhesion molecules in humans. Environ. Health Perspect., 2006, 114(1), 51-58.
49. Apopa, P.L.; Qian, Y.; Shao, R.; Guo, N.L.; Schwegler-Berry, D.; Pacurari, M.; Porter, D.; Shi, X.; Vallyathan, V.; Castranova, V.; Flynn, D.C. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part. Fibre Toxicol, 2009, 6, 1-14.
50. Yu, M.; Mo, Y.; Wan, R.; Chien, S.; Zhang, X.; Zhang, Q. Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles. Toxicol. Lett., 2010, 195(1), 82-89.
51. Nel, A.; Xia, T.; Madler, L.; Li, N. Toxic potential of materials at the nanolevel. Science, 2006, 311(5761), 622-627.
52. Rotsch, C.; Radmacher, M. Drug-induced changes of cytoskeletal structure and mechanics in fibroblasts: An atomic force microscopy study. Biophys. J., 2000, 78(1), 520-535.
53. Chiu, J.J.; Usami, S.; Chien, S. Vascular endothelial responses to altered shear stress: Pathologic implications for atherosclerosis. Ann. Med., 2009, 41(1), 19-28.
54. Gupta, A.K.; Curtis, A.S.G. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials, 2004, 25(15), 3029-3040.
55. Buyukhatipoglu, K.; Clyne, A.M. Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J. Biomed. Mater. Res. A, 2011, 96(1), 186-195.
56. Service, R.F. American Chemical Society meeting. Nanomaterials show signs of toxicity. Science, 2003, 300(5617), 243.
57. Cui, L.F.; Yang, Y.; Hsu, C.M.; Cui, Y. Carbon-silicon core-shell nanowires as high capacity electrode for lithium ion batteries. Nano Lett., 2009, 9(9), 3370-3374.
58. Gupta, B.K.; Grover, V.; Gupta, G.; Shanker, V. Highly efficient luminescence from hybrid structures of ZnO/multi-walled carbon nanotubes for high performance display applications. Nanotechnology, 2010, 21(47), 475701.
59. Guo, Y.Y.; Zhang, J.; Zheng, Y.F.; Yang, J.; Zhu, X.Q. Cytotoxic and genotoxic effects of multi-wall carbon nanotubes on human umbilical vein endothelial cells in vitro. Mutat. Res., 2011, 721(2), 184-191.
60. Kalishwaralal, K.; Banumathi, E.; Ram Kumar Pandian, S.; Deepak, V.; Muniyandi, J.; Eom, S.H.; Gurnathan, S. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf. B Biointerfaces, 2009, 73(1), 51-57.
61. Rosas-Hernández, H.; Jiménez-Badillo, S.; Martínez-Cuevas, P.P.; Gracia-Espino, E.; Terrones, H.; Terrones, M.; Hussain, S.M.; Ali, S.F.; González, C. Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicol. Lett., 2009, 191(2-3), 305-313.
62. Tan, W.; Wang, K.; He, X.; Zhao, X.J.; Drake, T.; Wang, L.; Bagwe, R.P. Bionanotechnology based on silica nanoparticles. Med. Res. Rev., 2004, 24(5), 621-638.
63. Lu, J.; Liong, M.; Zink, J.I.; Tamanoi, F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small, 2007, 3(8), 1341-1346.
64. Napierska, D.; Thomassen, L.C.; Rabolli, V.; Lison, D.; Gonzalez, L.; Kirsch-Volders, M.; Martens J.A.; Hoet, P.H. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small, 2009, 5(7), 846-853.
65. Liu, X.; Sun, J. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials, 2010, 31(32), 8198-8209.
66. Peters, K.; Unger, R.E.; Kirkpatrick, C.J.; Gatti, A.M.; Monari, E. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. J. Mater. Sci. Mater. Med., 2004, 15(4), 321-325.
67. Daroczi, B.; Kari, G.; McAleer, M.F.; Wolf, J.C.; Rodeck, U.; Dicker, A.P. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model. Clin. Cancer Res., 2006, 12(23), 7086-7091.
68. Lao, F.; Chen, L.; Li, W.; Ge, C.; Qu, Y.; Sun, Q.; Zhao, Y.; Han, D.; Chen, C. Fullerene nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and inhibit JNK-related apoptosis. A.C.S Nano, 2009, 3(11), 3358-3368.
69. Miller, D.T.; Ridker, P.M.; Libby, P.; Kwiatkowski, D.J. Atherosclerosis: the path from genomics to therapeutics. J. Am. Coll. Cardiol., 2007, 49(15), 1589-1599.
70. Dong, Z.M.; Chapman, S.M.; Brown, A.A.; Frenette, P.S.; Hynes, R.O.; Wagner, D.D. The combined role of P- and E-selectins in atherosclerosis. J. Clin. Invest., 1998, 102(1), 145-152.
71. Theoharis, S.; Krueger, U.; Tan, P.H.; Haskard, D.O.; Weber, M.; George, A.J. Targeting gene delivery to activated vascular endothelium using anti E/P-Selectin antibody linked to PAMAM dendrimers. J. Immunol. Methods, 2009, 343(2), 79-90.